SG10202108497TA - Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones - Google Patents

Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones

Info

Publication number
SG10202108497TA
SG10202108497TA SG10202108497TA SG10202108497TA SG10202108497TA SG 10202108497T A SG10202108497T A SG 10202108497TA SG 10202108497T A SG10202108497T A SG 10202108497TA SG 10202108497T A SG10202108497T A SG 10202108497TA SG 10202108497T A SG10202108497T A SG 10202108497TA
Authority
SG
Singapore
Prior art keywords
expression
biologically active
elevated levels
synthesis system
active proteins
Prior art date
Application number
SG10202108497TA
Other languages
English (en)
Inventor
Alice Yam
Dan Groff
Patrick Rivers
Christopher D Thanos
Original Assignee
Sutro Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sutro Biopharma Inc filed Critical Sutro Biopharma Inc
Publication of SG10202108497TA publication Critical patent/SG10202108497TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10202108497TA 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones SG10202108497TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361813914P 2013-04-19 2013-04-19
US201461937069P 2014-02-07 2014-02-07

Publications (1)

Publication Number Publication Date
SG10202108497TA true SG10202108497TA (en) 2021-09-29

Family

ID=50733442

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201508642WA SG11201508642WA (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones
SG10202108497TA SG10202108497TA (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201508642WA SG11201508642WA (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones

Country Status (13)

Country Link
US (3) US10190145B2 (enExample)
EP (1) EP2986731B1 (enExample)
JP (2) JP6463732B2 (enExample)
KR (1) KR102289258B1 (enExample)
CN (1) CN105283556B (enExample)
AU (1) AU2014253785B2 (enExample)
CA (1) CA2909516C (enExample)
DK (1) DK2986731T3 (enExample)
ES (1) ES2922358T3 (enExample)
HU (1) HUE059565T2 (enExample)
IL (1) IL242148B (enExample)
SG (2) SG11201508642WA (enExample)
WO (1) WO2014172631A2 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102289258B1 (ko) * 2013-04-19 2021-08-11 서트로 바이오파마, 인크. 상승된 수준의 외인성 샤페론을 갖는 세포 추출물을 이용한 박테리아 세포 비함유 합성 시스템에서의 생물학적 활성 단백질의 발현
EP3164501A4 (en) 2014-07-02 2018-01-17 Sutro Biopharma, Inc. High growth capacity auxotrophic escherichia coli and methods of use
RU2739500C2 (ru) 2014-11-05 2020-12-25 Дженентек, Инк. Способы получения двуцепочечных белков в бактериях
CN108064308B (zh) 2014-11-05 2023-06-09 豪夫迈·罗氏有限公司 细菌中产生双链蛋白的方法
US10487133B2 (en) 2014-12-19 2019-11-26 Sutro Biopharma, Inc. Codon optimization for titer and fidelity improvement
MX391051B (es) * 2014-12-30 2025-03-21 Celgene Corp Anticuerpos anti-cd47 y usos de los mismos.
CN107531749A (zh) * 2015-03-06 2018-01-02 豪夫迈·罗氏有限公司 超纯化DsbA和DsbC及其制备和使用方法
US20170029798A1 (en) * 2015-07-27 2017-02-02 Cellivery Therapeutics, Inc. Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)
WO2017031476A2 (en) * 2015-08-20 2017-02-23 Genentech, Inc. Purification of fkpa and uses thereof for producing recombinant polypeptides
CN105198983B (zh) * 2015-09-11 2018-11-06 中国石油大学(华东) 一种利于七次跨膜蛋白ccr5功能性表达的方法
CN106190940B (zh) * 2016-07-19 2019-06-14 北京三元基因药业股份有限公司 表达抗TNF抗体Fab片段的重组大肠杆菌工程菌
CN106399352B (zh) * 2016-11-09 2020-04-17 华东理工大学 调节目标蛋白表达的折叠因子及其应用
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
US12227778B2 (en) 2016-12-30 2025-02-18 Nature's Toolbox, Inc. Cell-free expression system having novel inorganic polyphosphate-based energy regeneration
MX2019007910A (es) 2016-12-30 2019-12-05 Sutrovax Inc Conjugados de polipeptido-antigeno con aminoacidos no naturales.
DK3562940T3 (da) * 2016-12-30 2022-07-11 Natures Toolbox Inc Cellefrit ekspressionssystem med hidtil ukendt, uorganisk polyphosphatbaseret energiregeneration
JP7325341B2 (ja) 2017-07-11 2023-08-14 シンソークス,インク. 非天然ヌクレオチドの組み込み及びその方法
BR112020002272A2 (pt) 2017-08-03 2020-07-28 Synthorx, Inc. conjugados de citocina para o tratamento de doenças autoimunes
US20200181670A1 (en) * 2017-08-11 2020-06-11 Synvitrobio, Inc. Improved In Vitro Transcription/Translation (TXTL) System and Use Thereof
WO2019127469A1 (zh) * 2017-12-29 2019-07-04 康码(上海)生物科技有限公司 一种高效的能源再生体系(bes)、试剂盒及其制备方法
KR102812714B1 (ko) 2018-02-26 2025-05-27 신톡스, 인크. Il-15 접합체 및 이의 용도
SG11202100023XA (en) 2018-07-11 2021-01-28 Actym Therapeutics Inc Engineered immunostimulatory bacterial strains and uses thereof
WO2020096959A1 (en) 2018-11-05 2020-05-14 Genentech, Inc. Methods of producing two chain proteins in prokaryotic host cells
JP7636323B2 (ja) 2018-11-08 2025-02-26 シンソークス, インコーポレイテッド インターロイキン10コンジュゲートおよびその使用
WO2020097385A1 (en) * 2018-11-08 2020-05-14 Sutro Biopharma, Inc. E coli strains having an oxidative cytoplasm
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
CN113660946A (zh) 2019-02-06 2021-11-16 新索思股份有限公司 Il-2缀合物及其使用方法
US12024709B2 (en) 2019-02-27 2024-07-02 Actym Therapeutics, Inc. Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment
WO2021178001A1 (en) * 2020-03-05 2021-09-10 Curie Co. Inc. Methods for cell free protein expression of mature polypeptides derived from zymogens and proproteins
MX2022001776A (es) 2019-08-15 2022-03-17 Synthorx Inc Terapias de combinacion de inmuno oncologia con conjugados de il-2.
JP7758662B2 (ja) 2019-09-10 2025-10-22 シンソークス, インコーポレイテッド Il-2コンジュゲートおよび自己免疫疾患を治療するための使用方法
KR20220097445A (ko) 2019-11-04 2022-07-07 신톡스, 인크. 인터류킨 10 접합체 및 이의 용도
EP4056584A4 (en) * 2019-11-08 2024-06-05 Korea Institute of Ocean Science & Technology NOVEL HUMAN EPIDERMAL GROWTH FACTOR-TF FUSION PROTEIN AND USE THEREOF
CA3175683A1 (en) * 2020-04-29 2021-11-04 Xueyang FENG Compositions and methods for enhancing recombinant biosynthesis of cannabinoids
EP4171648A1 (en) 2020-06-25 2023-05-03 Synthorx, Inc. Immuno oncology combination therapy with il-2 conjugates and anti-egfr antibodies
KR20220000028U (ko) 2020-06-29 2022-01-05 채인자 농작물용 농약 간편 분무장치
AU2021342284A1 (en) * 2020-09-14 2023-04-20 Sutro Biopharma, Inc. Method for large scale production of antibodies using a cell-free protein synthesis system
MX2023004029A (es) 2020-10-09 2023-04-27 Synthorx Inc Terapia de combinacion de inmunoncologia con conjugados de il-2 y pembrolizumab.
EP4225375A1 (en) 2020-10-09 2023-08-16 Synthorx, Inc. Immuno oncology therapies with il-2 conjugates
EP4291243A1 (en) 2021-02-12 2023-12-20 Synthorx, Inc. Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding fragment thereof
TW202245843A (zh) 2021-02-12 2022-12-01 美商欣爍克斯公司 Il-2接合物及西米普利單抗(cemiplimab)之皮膚癌組合療法
TW202313117A (zh) 2021-06-03 2023-04-01 美商欣爍克斯公司 包含il-2接合物及西妥昔單抗(cetuximab)之頭頸癌組合療法
EP4452327A1 (en) 2021-12-20 2024-10-30 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
WO2023122750A1 (en) 2021-12-23 2023-06-29 Synthorx, Inc. Cancer combination therapy with il-2 conjugates and cetuximab
US12163190B2 (en) * 2022-06-17 2024-12-10 Insitro, Inc. In situ sequencing of RNA transcripts with non-uniform 5 prime ends
CN115028691B (zh) * 2022-06-29 2024-09-10 青岛硕景生物科技有限公司 一种检测试纸用的独立质控系统、杂交瘤细胞株、质控线用包被单克隆抗体及其应用
WO2024136899A1 (en) 2022-12-21 2024-06-27 Synthorx, Inc. Cancer therapy with il-2 conjugates and chimeric antigen receptor therapies
WO2024196937A1 (en) 2023-03-20 2024-09-26 Synthorx, Inc. Cancer therapy with il-2 peg conjugates
CN116925196B (zh) * 2023-06-08 2025-04-18 齐鲁工业大学(山东省科学院) 小分子热休克蛋白rsp_1572在提高宿主菌环境耐受性中的应用
WO2025158385A1 (en) 2024-01-25 2025-07-31 Genzyme Corporation Pegylated il-2 for suppressing adaptive immune response to gene therapy
CN118048325B (zh) * 2024-04-16 2024-07-16 天津凯莱英生物科技有限公司 酶的高通量筛选方法及酶库的构建方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10145694A1 (de) 2001-09-17 2003-04-03 Roche Diagnostics Gmbh Verfahren zur Erhöhung der Löslichkeit, der Expressionsrate und der Aktivität von Proteinen während der rekombinanten Herstellung
US20060134739A1 (en) 2003-03-11 2006-06-22 Chatterjee Deb K Synthesis of proteins by cell-free protein expression
JP2005253432A (ja) 2004-03-15 2005-09-22 Sekisui Chem Co Ltd タンパク質の生産方法、並びにそれに使用するための組成物、試薬及びキット
JP4561243B2 (ja) 2004-08-27 2010-10-13 株式会社豊田中央研究所 無細胞タンパク質合成系のための媒体
AU2007325952B8 (en) * 2006-06-29 2013-06-27 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of proteins containing unnatural amino acids
US7871794B2 (en) * 2007-01-18 2011-01-18 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds
EP2376647B1 (en) 2009-01-12 2014-03-05 Sutro Biopharma, Inc. Mono charging system for selectively introducing non-native amino acids into proteins using an in vitro protein synthesis system
CN102732548A (zh) 2012-05-16 2012-10-17 中国农业大学 一种表达蛇毒激肽原酶的高效麦胚无细胞蛋白合成系统的建立及应用
CA2887355C (en) * 2012-10-12 2023-03-07 Sutro Biopharma, Inc. Proteolytic inactivation of select proteins in bacterial extracts for improved expression
KR102289258B1 (ko) * 2013-04-19 2021-08-11 서트로 바이오파마, 인크. 상승된 수준의 외인성 샤페론을 갖는 세포 추출물을 이용한 박테리아 세포 비함유 합성 시스템에서의 생물학적 활성 단백질의 발현

Also Published As

Publication number Publication date
EP2986731B1 (en) 2022-05-18
SG11201508642WA (en) 2015-11-27
EP2986731A2 (en) 2016-02-24
DK2986731T3 (da) 2022-08-01
AU2014253785B2 (en) 2018-07-19
US20140315245A1 (en) 2014-10-23
JP2016518833A (ja) 2016-06-30
HK1220993A1 (en) 2017-05-19
CA2909516A1 (en) 2014-10-23
US20210054429A1 (en) 2021-02-25
KR102289258B1 (ko) 2021-08-11
WO2014172631A3 (en) 2014-12-18
JP2018157837A (ja) 2018-10-11
AU2014253785A1 (en) 2015-11-05
US10774354B2 (en) 2020-09-15
JP6463732B2 (ja) 2019-02-06
HUE059565T2 (hu) 2022-11-28
WO2014172631A4 (en) 2015-02-19
CN105283556B (zh) 2020-07-14
CA2909516C (en) 2023-03-07
KR20160002913A (ko) 2016-01-08
ES2922358T3 (es) 2022-09-13
IL242148B (en) 2019-03-31
CN105283556A (zh) 2016-01-27
US10190145B2 (en) 2019-01-29
US20190161781A1 (en) 2019-05-30
WO2014172631A2 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
IL242148B (en) Expression of biologically active proteins in a cell-free bacterial expression system containing high levels of external chaperones
IL273504A (en) Compositions for cell culture with antioxidants and methods for polypeptide production
IL237530A0 (en) Gene and protein expression characteristics of adherent stromal cells grown in 3D
SG11201402194RA (en) Cd40l expressing mammalian cells and their use
HRP20190484T1 (hr) Pripravci stanične kulture i postupci proizvodnje polipeptida
EP2895594A4 (en) ELECTROSYNTHETIC MICROBIAL CELLS
GB201100180D0 (en) Tumour cell and tissue culture
ZA201409367B (en) A method to produce a medicinal product comprising a biologically active protein and the resulting product
IL240339A0 (en) An algal cell with impaired chlorophyll with enhanced growth and production
EP2753346A4 (en) CERAMIDASE AND CELL DIFFERENTIATION
EP3072953A4 (en) Cell culture container and container in which cell culture has been accommodated
EP3037516A4 (en) Liquid delivery device and cell culture device using same
SG11201507828VA (en) Method for culturing hepatoblast-like cells and culture product thereof
IL224813B (en) Compositions comprising th1 killer cells and uses thereof
CA144251S (en) Sofa
PL2861713T3 (pl) Sposób hodowli komórkowej i system
EP3068875A4 (en) Post-natal hematopoeitic endothelial cells and their isolation and use
EP2964746A4 (en) FERMENTATION MONITORING DEVICE FOR FUEL CELL
PT2753346T (pt) Ceramidase e diferenciação celular
EP3075846A4 (en) Cell culture medium and culture method using same
EP2912164A4 (en) MICRO-RNAS AND CELL PROGRAMMING
PL3008165T3 (pl) Kontrola konduktywności w fermentacji beztlenowej
EP3042949A4 (en) Cultivation method for bacteria belonging to genus collimonas and storage method
WO2012166875A9 (en) Modulating innate immune cell activity by lunasin and selected cytokines
GB201113046D0 (en) Fermenter and the method of fermentation